𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second-line chemotherapy in patients with primary unknown cancer

✍ Scribed by Makiko Ono; Masashi Ando; Kan Yonemori; Harukaze Yamamoto; Taizo Hirata; Chikako Shimizu; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
168 KB
Volume
137
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine and docetaxel as front-line
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
✍ Damien Pouessel; StΓ©phane Culine; Catherine Becht; Marc Ychou; Gilles Romieu; Mi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The current study was performed to evaluate the efficacy and toxicity of a noncisplatin‐based chemotherapy regimen combining gemcitabine and docetaxel as front‐line chemotherapy for patients with carcinoma of an unknown primary site. ## METHODS Patients were to receive

Gemcitabine and docetaxel as front-line
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
✍ Alberto MuΓ±oz; JosΓ© RamΓ³n BarcelΓ³; Guillermo LΓ³pez-Vivanco πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.

Second primary tumors in patients with o
Second primary tumors in patients with oral cancer
✍ Gina L. Day; William J. Blot πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 522 KB

Background. Patients with cancer of the oral cavity and pharynx have been described to be particularly susceptible to the development of new cancers. Methods. Using data collected during 1973-1987 by nine population-based cancer registries in the United States, the authors evaluated risks of second